Royalty Pharma plc Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue630.6M622.0M609.3M578.7M568.2M593.6M564.7M537.3M
Cost of Goods Sold1.2M0000000
Gross Profit629.4M622.0M609.3M578.7M568.2M593.6M564.7M537.3M
R&D Expenses40.0M51.0M50.5M300.5M50.5M500K500K500K
Operating Expenses-3.1M233.6M182.1M368.9M34.1M232.1M-170.4M267.6M
Operating Income632.5M388.4M427.2M209.8M534.2M361.5M735.1M269.6M
Other Income / Gains-164.2M-32.5M17.1M-119.2M-100.7M-27.2M71.3M-75.3M
Net Income295.0M214.2M288.2M30.2M238.3M208.2M544.0M102.0M
EPS (Diluted)0.680.641.050.0940.550.471.220.23
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.9981.001.001.001.001.001.001.00
General And Administrative Expenses159.0M164.3M118.7M179.8M110.7M67.6M56.7M54.7M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses159.0M164.3M118.7M179.8M110.7M67.6M56.7M54.7M
Other Expenses-202.1M18.8M12.9M-111.4M-127.1M164.0M-227.6M212.4M
Cost And Expenses-1.9M233.6M182.1M368.9M34.1M232.1M-170.4M267.6M
Interest Income6.2M7.1M6.9M8.3M11.3M9.0M17.5M13.4M
Interest Expense93.7M94.2M79.6M68.7M65.3M65.8M66.5M49.0M
Depreciation And Amortization1.2M1.2M1.3M00000
Ebitda563.1M451.3M525.1M159.3M498.7M400.1M872.9M243.4M
Ebitdaratio0.8930.7260.8620.2750.8780.6741.5460.453
Operating Income Ratio1.0030.6240.7010.3630.940.6091.3020.502
Income Before Tax468.3M355.9M444.2M90.6M433.4M334.4M806.4M194.4M
Income Before Tax Ratio0.7430.5720.7290.1570.7630.5631.4280.362
Income Tax Expense00000000
Net Income Ratio0.4680.3440.4730.0520.4190.3510.9630.19
Epsdiluted0.530.500.670.070.410.471.210.23
Weighted Average Shs Out431.9M431.9M431.9M423.5M435.5M446.0M446.0M451.0M
Weighted Average Shs Out Dil559.6M559.6M559.6M562.3M578.1M589.0M593.0M596.9M